Skip to main content

Table 1 Comparison of the demographic and laboratory data in control and patient groups

From: Relationship between circulating microparticles and hypertension and other cardiac disease biomarkers in the elderly

  Control group
(N = 47)
Patient group
(N = 47)
 
Age (years) 71.6 ± 9.1 72.7 ± 7.2 = 0.5160
Gender (M/F) 19/28 15/32 = 0.3910
ALT (U/L) 18 (14–22) 16 (13–21) = 0.3040
GGT (U/L) 20 (15–35) 19 (15–32) = 0.6270
CRP (mg/L) 4.09 (1.83–7.76) 5.20 (2.39–10.80) = 0.3100
WBC (×10^9/L) 7.2 ± 2.0 7.4 ± 2.0 = 0.6120
Neutrophyl (×10^9/L) 4.3 ± 1.8 4.5 ± 1.8 = 0.5880
Lymphocyte (×10^9/L) 2.1 ± 0.7 2.1 ± 0.8 = 0.9360
NLR 2.07 (1.34–2.81) 2.13 (1.41–3.09) = 0.5010
PLT (×10^9/L) 216.9 ± 57.4 247.2 ± 64.7 = 0.0250
PDW (fL) 11.5 (11.0–13.3) 11.7 (10.9–13.3) = 0.8050
MPV (fL) 10.5 ± 0.9 10.3 ± 0.8 = 0.4810
PCT (%) 0.23 (0.21–0.25) 0.26 (0.20–0.28) = 0.1650
MPslag time (min) 12.87 (10.33–15.67) 12.00 (10.67–14.00) = 0.5960
MPs ETP (nmol/L•min) 2092.8 ± 676.1 2029.5 ± 615.9 = 0.6450
MPsPeak (nmol/L) 377.43 (294.73–463.98) 388.27 (315.29–473.32) = 0.5040
MPsttPeak (min) 15.67 (13.00–19.21) 14.44 (13.00–16.38) = 0.2700
MPsstartTail (min) 31 (28–35) 30 (27–33) = 0.2730
  1. Meaningful difference was found for only PLT between patient and control groups